It's again the right question to ask because these are incredible new therapies and, in many cases, are providing people a very long or extended lifespan, if not a cure. As you point out, right now in the case of CAR-T, for instance, when we send a patient to Pennsylvania or to Seattle to be treated, it can cost upwards of a million dollars for the patient—often covered by the government. By creating it in our own infrastructure here in Canada, we'll be able to control those costs.
Stéph and I talk all the time about the concept of creating B corps, for instance, things that actually care more about Canadians and their patients than we do about investors essentially. I think there are ways to be creative, get inventions developed here and maintained here and priced for the way the Canadian system can stand. I think its soluble. I just think we've gotten ourselves into a mindset that we have to do it the big pharma way, and I think there are many ways to get around that. As you point out, we already have the cost down to about $100,000 per patient. I know we can do way better than that, because we've only treated a small number of patients so far. If we build our own infrastructure, I think the cost can be controlled and brought down.
You also have to weigh into that the cost of having a curative therapy versus therapies we currently give that are not curative, and that costs a lot of money too. I think there's a rationale for investing in these new technologies.